Pacific Biosciences of California Inc. (PACB)

2.65
0.01 0.57
NASDAQ : Health Technology
Prev Close 2.63
Open 2.64
Day Low/High 2.60 / 2.66
52 Wk Low/High 2.02 / 5.70
Volume 27.46K
Avg Volume 791.90K
Exchange NASDAQ
Shares Outstanding 131.88M
Market Cap 344.20M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of PACB February 20th Options Trading

First Week of PACB February 20th Options Trading

Investors in Pacific Biosciences of California Inc saw new options become available this week, for the February 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new February 20th contracts and identified one put and one call contract of particular interest.

Pacific Biosciences Appoints Kathy Ordonez To Board Of Directors

Pacific Biosciences Appoints Kathy Ordonez To Board Of Directors

Industry Veteran Previously Served as SVP at Quest Diagnostics and CEO of Celera and of Roche Molecular Systems

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume

Pacific Biosciences Of California (PACB) Flagged As Strong On High Volume

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Researchers Use PacBio Sequencing To Create More Complete Human Genome Reference And Discover New Forms Of Structural Variation; Paper Published In Nature

Researchers Use PacBio Sequencing To Create More Complete Human Genome Reference And Discover New Forms Of Structural Variation; Paper Published In Nature

Several New Studies Highlight Growing Trend of Scientists Using SMRT(R) Sequencing Technology to Reveal Complexity and Medically Relevant Information in the Human Genome

New DNA Sequencing Facility Established In China Based On PacBio's SMRT Sequencing Platform

New DNA Sequencing Facility Established In China Based On PacBio's SMRT Sequencing Platform

PacBio RS II Systems Will Support Sequencing Services for Human, Animal, Plant and Bacterial Applications

Strong On High Volume: Pacific Biosciences Of California (PACB)

Strong On High Volume: Pacific Biosciences Of California (PACB)

Trade-Ideas LLC identified Pacific Biosciences of California (PACB) as a strong on high relative volume candidate

Commit To Purchase Pacific Biosciences of California At $5, Earn 39.9% Annualized Using Options

Commit To Purchase Pacific Biosciences of California At $5, Earn 39.9% Annualized Using Options

Investors eyeing a purchase of Pacific Biosciences of California Inc stock, but cautious about paying the going market price of $5.63/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $5 strike, which has a bid at the time of this writing of 35 cents.

Pacific Biosciences Releases New DNA Sequencing Chemistry To Enhance Read Length And Accuracy For The Study Of Human And Other Complex Genomes

Pacific Biosciences Releases New DNA Sequencing Chemistry To Enhance Read Length And Accuracy For The Study Of Human And Other Complex Genomes

New Chemistry Boosts Accuracy and Increases Average Read Length to 10,000 to 15,000 Bases Accelerating Innovative Genomic Research

Human Longevity Inc. Adds PacBio(R) Sequencing To Enable Additional Insight Into Human Genetic Variation

Human Longevity Inc. Adds PacBio(R) Sequencing To Enable Additional Insight Into Human Genetic Variation

Purchase of Two PacBio RS II Sequencing Systems Will Be Used to Help Build HLI's Genotype/Phenotype Database

Macrogen Selects Single Molecule, Real-Time Sequencing For High-Quality De Novo Asian Human Reference Genomes

Macrogen Selects Single Molecule, Real-Time Sequencing For High-Quality De Novo Asian Human Reference Genomes

Purchase of Two PacBio RS II Sequencing Systems Will Support Global Sequencing Service Business for Human, Animal, Plant and Bacterial Applications

Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease Pathogens More Effectively Than Short-Read Technologies

Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease Pathogens More Effectively Than Short-Read Technologies

Series of Recent Publications Highlight Unique Advantages of Long-Read SMRT Sequencing for Understanding Spread of Antibiotic Resistance

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Single Molecule, Real-Time (SMRT) DNA Sequencing Technology From Pacific Biosciences To Be Featured In 20 Presentations At The American Society For Microbiology 2014 Annual Meeting

Single Molecule, Real-Time (SMRT) DNA Sequencing Technology From Pacific Biosciences To Be Featured In 20 Presentations At The American Society For Microbiology 2014 Annual Meeting

Winner of Last Year's SMRT Grant Program Announced; "SMRTest Microbe" Grant Program Begins Worldwide

Why Pacific Biosciences of California (PACB) Stock Is Surging Today

Why Pacific Biosciences of California (PACB) Stock Is Surging Today

Pacific Biosciences of California (PACB) surged Thursday after the company reported first-quarter earnings that beat analysts' expectations.

HistoGenetics Selects PacBio(R) DNA Sequencing Platform To Enhance Human Leukocyte Antigen (HLA) Typing

HistoGenetics Selects PacBio(R) DNA Sequencing Platform To Enhance Human Leukocyte Antigen (HLA) Typing

Leading HLA Typing Company Purchases Two PacBio RS II Sequencing Systems

First Week of PACB April 19th Options Trading

First Week of PACB April 19th Options Trading

Investors in Pacific Biosciences of California Inc saw new options become available this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PACB options chain for the new April 19th contracts and identified one put and one call contract of particular interest.

4 Biotech Stocks Under $10 to Watch

4 Biotech Stocks Under $10 to Watch

Keep these under-$10 biotech stocks trading on unusual volume on your radar.

TheStreet Quant Rating: D- (Sell)